Abstract
In humans, obesity plays a critical role in pulmonary inflammation, and is an important risk factor for the development of several inflammatory respiratory diseases. Therefore, understanding the mechanisms that generate mediators in the setting of obesity may help to recognize the link between obesity and chronic respiratory diseases, like the increased incidence and severity of asthma in obese individuals. NMR spectroscopy of exhaled breath condensate (EBC, a non-invasive matrix to access the lung epithelial lining fluid) can unambiguously identify biomarkers characterizing different pulmonary physiopathological states. In this study we aimed at verifying if NMR-based metabolomics of EBC, combined with orthogonal projections to latent structures-discriminant analysis, could possibly recognize specific biomarkers to map the obese metabolic respiratory phenotype. Obese and lean control subjects could be distinguished in a statistical model presenting high quality parameters (R2 = 0.904 and Q2 = 0.871). Identified airway metabolites linked to the inflammation processes demonstrate that obesity constitutes a specific inflammatory metabolic phenotype (metabotype). It is concluded that the noninvasive EBC matrix is suitable to selectively investigate the obesity-related lung inflammation.
References
Calvani, R., Miccheli, A., Capuani, G., Tomassini Miccheli, A., Puccetti, C., Delfini, M., et al. (2010). Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype. International Journal of Obesity, 34, 1095–1098.
Carraro, S., Rezzi, S., Reniero, F., Héberger, K., Giordano, G., Zanconato, S., et al. (2007). Metabolomics applied to exhaled breath condensate in childhood asthma. American Journal of Respiratory and Critical Care Medicine, 175, 986–990.
de Laurentiis, G., Paris, D., Melck, D., Maniscalco, M., Marsico, S., Corso, G., et al. (2008). Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy. European Respiratory Journal, 32, 1175–1183.
de Laurentiis, G., Paris, D., Melck, D., Montuschi, P., Maniscalco, M., Bianco, A., et al. (2013). Separating smoking-related diseases using NMR-based metabolomics of exhaled breath condensate. Journal of Proteome Research, 12, 1502–1511.
Eriksson, L., Johansson, E., Kettaneh-Wold, N., Trygg, J., Wikström, C., & Wold, S. (2006). Multi- and megavariate data analysis. Part I: Basic principles and applications (2nd ed.). Umeå: Umetrics AB.
Franssen, F. M., O’Donnell, D. E., Goossens, G. H., Blaak, E. E., & Schols, A. M. (2008). Obesity and the lung: 5. Obesity and COPD. Thorax, 63, 1110–1117.
Human Metabolome Database. (2015). www.hmdb.ca/metabolites/HMDB00142.
Jensen, P. R., Peitersen, T., Karlsson, M., In’t Zandt, R., Gisselsson, A., Hansson, G., et al. (2009). Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. The Journal of biological chemistry, 284, 36077–36082.
Konter, J., Baez, E., & Summer, R. S. (2013). Obesity: “priming” the lung for injury. Pulmonary Pharmacology & Therapeutics, 26, 427–429.
Kovacic, P., & Somanathan, R. (2009). Pulmonary toxicity and environmental contamination: radicals, electron transfer, and protection by antioxidants. Reviews of Environmental Contamination and Toxicology, 201, 41–69.
Luster, A. D., Alon, R., & von Andrian, U. H. (2005). Immune cell migration in inflammation: present and future therapeutic targets. Nature Immunology, 6, 1182–1190.
Mancuso, P. (2010). Obesity and lung inflammation. Journal of Applied Physiology (1985), 108, 722–728.
Montuschi, P., Paris, D., Melck, D., Lucidi, V., Ciabattoni, G., Raia, V., et al. (2012). NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax, 67, 222–228.
Montuschi, P., Paris, D., Montella, S., Melck, D., Mirra, V., Santini, G., et al. (2014). Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 190, 229–233.
Motta, A., Paris, D., D’Amato, M., Melck, D., Calabrese, C., Vitale, C., et al. (2014). NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures. J Proteome Research, 13, 6107–6120.
Persoz, C., Achard, S., Momas, I., & Seta, N. (2012). Inflammatory response modulation of airway epithelial cells exposed to formaldehyde. Toxicology Letters, 211, 159–163.
Salome, C. M., King, G. G., & Berend, N. (2010). Physiology of obesity and effects on lung function. Journal of Applied Physiology (1985), 108, 206–211.
Sutherland, E. R. (2014). Linking obesity and asthma. Annals of the New York Academy of Sciences, 1311, 31–41.
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., et al. (2013). Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature, 496, 238–242.
Wolak, J. E., Esther, C. R, Jr, & O’Connell, T. M. (2009). Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients. Biomarkers, 14, 55–60.
Xia, J., Mandal, R., Sinelnikov, I. V., Broadhurst, D., & Wishart, D. S. (2012). MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Research, 40, W127–133.
Acknowledgments
The authors thank patients for their contribution to the study.
Conflict of interest
All authors declare that they have no conflict of interest.
Compliance with Ethical Requirements
All institutional, national and international ethical guidelines for the patients were followed.
Author information
Authors and Affiliations
Corresponding author
Additional information
Debora Paris, Mauro Maniscalco, and Dominique Melck contributed equally to this work.
Matteo Sofia passed away untimely on September 17, 2013.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Paris, D., Maniscalco, M., Melck, D. et al. Inflammatory metabolites in exhaled breath condensate characterize the obese respiratory phenotype. Metabolomics 11, 1934–1939 (2015). https://doi.org/10.1007/s11306-015-0805-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11306-015-0805-8